Short Interest in Advanced Medical Isotope Corporation (OTCMKTS:RDGL) Declines By 86.5%

Advanced Medical Isotope Corporation (OTCMKTS:RDGL) saw a significant drop in short interest in January. As of January 15th, there was short interest totaling 7,733 shares, a drop of 86.5% from the December 31st total of 57,097 shares. Based on an average trading volume of 963,198 shares, the days-to-cover ratio is currently 0.0 days. Currently, 0.0% of the company’s stock are sold short. Currently, 0.0% of the company’s stock are sold short. Based on an average trading volume of 963,198 shares, the days-to-cover ratio is currently 0.0 days.

Advanced Medical Isotope Price Performance

OTCMKTS RDGL opened at $0.07 on Thursday. The company’s fifty day simple moving average is $0.07 and its 200-day simple moving average is $0.09. Advanced Medical Isotope has a 52 week low of $0.04 and a 52 week high of $0.17.

Advanced Medical Isotope Company Profile

Vivos Inc, a radiation oncology medical device company, develops brachytherapy devices for the treatment of non-resectable tumors in the United States. It develops yttrium-90 based RadioGel device, an injectable particle-gel for brachytherapy radiation treatment of cancerous tumors in people and animals; and IsoPet for the treatment of solid tumors in animals. The company was formerly known as Advanced Medical Isotope Corporation and changed its name to Vivos Inc in December 2017. Vivos Inc was incorporated in 1994 and is headquartered in Richland, Washington.